Pharmacovigilance produces valuable safety data, but is it used to its full value, and how can primary healthcare workers make more use of PV findings in diagnosis and prescribing?

With the PAVIA project ending, participants identified what makes for a thriving pharmacovigilance system in countries burdened by poverty related diseases.

The International Medication Safety Network has medication errors in its sights, developing and distributing safety practices that promote medication safety.

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?